After spending time on the FDA's Category 2 list flagged for "significant safety concerns" BPC-157 is now being removed from that restrictive classification and scheduled for a Pharmacy Compounding Advisory Committee (PCAC) review on July 23, 2026
Yes, Epithalon integrates well with comprehensive longevity protocols including other peptides, hormone optimization, NAD+ therapy, senolytics, and lifestyle interventions
Do I need to follow a specific diet
Proper packaging: Quality peptides arrive in sealed vials with appropriate labeling, not loose containers or unclear markings
In practice, this means container condition belongs in every storage check, not only in a final inspection
Injection site: subcutaneous, abdomen